13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
64 檔
25.6%
Q1 2025 季度申报显示，Braidwell LP 披露的美股组合总市值为 US$27.0亿，涵盖 64 个不同之权益投资仓位。
在 Q1 2025，Braidwell LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 20 个仓位并完全清仓 22 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Braidwell LP 的前 5 大核心持股（包含 GH 1.25 02-15-31, NVCR 0 11-01-25, NBIX 等）合计占整体申报市值的 25.6%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31债券 | Guardant Health Inc | 债券 | 7.99% | -3.42% | EXIT | |
| 2 | NVCR 0 11-01-25债券 | Novocure LTD | 债券 | 4.80% | — | — | |
| 3 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 4.63% | -0.77% | +32.17% | |
| 4 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 3.55% | — | — | |
| 5 | RGEN 1 12-15-28债券 | Repligen CORP | 债券 | 3.37% | -2.68% | -12.50% | |
| 6 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 3.35% | -1.46% | +99.15% | |
| 7 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.20% | -0.07% | -7.00% | |
| 8 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | 债券 | 3.15% | — | — | |
| 9 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 3.09% | -2.44% | -12.89% | |
| 10 | ALGN | Align Technology Inc | 股票-医疗保健 | 2.96% | — | +41.41% | |
| 11 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 2.90% | — | — | |
| 12 | CGON | Cg Oncology Inc | 股票-其他 | 2.83% | -2.22% | EXIT | |
| 13 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 2.54% | +0.20% | +99.87% | |
| 14 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | 债券 | 2.53% | — | -55.38% | |
| 15 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.23% | +0.14% | +42.31% | |
| 16 | DHR | Danaher CORP | 股票-医疗保健 | 2.23% | +0.18% | — | |
| 17 | GKOS | Glaukos CORP | 股票-医疗保健 | 2.16% | +0.32% | +116.16% | |
| 18 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.10% | -2.39% | EXIT | |
| 19 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 2.05% | +0.48% | -21.12% | |
| 20 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.02% | -1.34% | EXIT | |
| 21 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 2.02% | +0.41% | -7.29% | |
| 22 | GH | Guardant Health Inc | 股票-医疗保健 | 1.99% | -0.72% | -53.39% | |
| 23 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.90% | +0.53% | +5.43% | |
| 24 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.69% | -0.05% | +3.07% | |
| 25 | BBIO 2.25 02-01-29债券 | Bridgebio Pharma Inc | 债券 | 1.54% | — | -9.33% | |
| 26 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | 债券 | 1.54% | — | — | |
| 27 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 1.53% | -0.01% | -43.14% | |
| 28 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.53% | -0.16% | +16.87% | |
| 29 | ATEC | Alphatec Holdings Inc | 股票-其他 | 1.52% | +1.30% | +0.07% | |
| 30 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.46% | +1.32% | — | |
| 31 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 1.37% | — | — | |
| 32 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.33% | -0.26% | +431.63% | |
| 33 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 1.27% | — | -21.27% | |
| 34 | ADPT | Adaptive Biotechnologies | 股票-其他 | 1.25% | — | — | |
| 35 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 1.22% | — | -2.95% | |
| 36 | PEN | Penumbra Inc | 股票-医疗保健 | 1.04% | -1.15% | EXIT | |
| 37 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 0.99% | — | +8.10% | |
| 38 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.99% | — | -27.43% | |
| 39 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.96% | +0.20% | — | |
| 40 | HROW | Harrow Inc | 股票-其他 | 0.89% | -0.18% | EXIT | |
| 41 | DXCM 0.375 05-15-28债券 | Dexcom Inc | 债券 | 0.80% | — | -69.23% | |
| 42 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.65% | +1.04% | — | |
| 43 | DXCM 0.25 11-15-25债券 | Dexcom Inc | 债券 | 0.63% | — | — | |
| 44 | XNCR | Xencor Inc | 股票-其他 | 0.62% | — | +168.99% | |
| 45 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.58% | — | — | |
| 46 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.57% | +0.98% | NEW | |
| 47 | MDGL | Madrigal Pharmaceuticals Inc | 股票-医疗保健 | 0.57% | — | — | |
| 48 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 0.53% | — | -35.74% | |
| 49 | REPL | Replimune Group Inc | 股票-其他 | 0.50% | — | -1.03% | |
| 50 | RGEN | Repligen CORP | 股票-医疗保健 | 0.37% | +0.70% | -71.23% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31债券 | Guardant Health Inc | +8% | NEW | 新建仓 |
| 2 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | +3.2% | NEW | 新建仓 |
| 3 | DHR | Danaher CORP | +2.2% | NEW | 新建仓 |
| 4 | ARGX | Argenx Se - Adr | +1.9% | +99.15% | 加仓 |
| 5 | KRYS | Krystal Biotech Inc | +1.6% | +99.87% | 加仓 |
| 6 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | +1.5% | NEW | 新建仓 |
| 7 | NUVL | Nuvalent Inc-a | +1.5% | +248.60% | 加仓 |
| 8 | 2655787D | Blueprint Medicines CORP | +1.4% | NEW | 新建仓 |
| 9 | ADPT | Adaptive Biotechnologies | +1.3% | NEW | 新建仓 |
| 10 | NBIX | Neurocrine Biosciences Inc | +1% | +32.17% | 加仓 |
| 11 | GKOS | Glaukos CORP | +0.9% | +116.16% | 加仓 |
| 12 | DYN | Dyne Therapeutics Inc | +0.9% | +431.63% | 加仓 |
| 13 | TMO | Thermo Fisher Scientific Inc | +0.9% | +42.31% | 加仓 |
| 14 | NVCR 0 11-01-25债券 | Novocure LTD | +0.8% | — | 不变 |
| 15 | LEGN | Legend Biotech Corp-adr | +0.7% | — | 不变 |
| 16 | ALGN | Align Technology Inc | +0.6% | +41.41% | 加仓 |
| 17 | ASND | Ascendis Pharma A/S | +0.6% | NEW | 新建仓 |
| 18 | MDGL | Madrigal Pharmaceuticals Inc | +0.6% | NEW | 新建仓 |
| 19 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | +0.4% | — | 不变 |
| 20 | ISRG | Intuitive Surgical Inc | +0.4% | +16.87% | 加仓 |
| 21 | ATEC | Alphatec Holdings Inc | +0.4% | +0.07% | 加仓 |
| 22 | TMDX | Transmedics Group Inc | +0.3% | -7.29% | 减仓 |
| 23 | CSTL | Castle Biosciences Inc | +0.3% | NEW | 新建仓 |
| 24 | XNCR | Xencor Inc | +0.2% | +168.99% | 加仓 |
| 25 | KIDS | Orthopediatrics CORP | +0.2% | — | 不变 |
| 26 | NEO 0.25 01-15-28债券 | Neogenomics Inc | +0.2% | -12.89% | 减仓 |
| 27 | BBIO 2.25 02-01-29债券 | Bridgebio Pharma Inc | +0.2% | -9.33% | 减仓 |
| 28 | ✓ | +0.2% | NEW | 新建仓 | |
| 29 | IRTC | Irhythm Holdings Inc | +0.2% | -21.12% | 减仓 |
| 30 | AARD | Aardvark Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 31 | DXCM 0.25 11-15-25债券 | Dexcom Inc | +0.1% | — | 不变 |
| 32 | INSP | Inspire Medical Systems Inc | +0.1% | +3.07% | 加仓 |
| 33 | BBNX | Beta Bionics Inc | +0.1% | NEW | 新建仓 |
| 34 | EWTX | Edgewise Therapeutics Inc | +0.1% | +5.43% | 加仓 |
| 35 | CGON | Cg Oncology Inc | 0% | — | 不变 |
| 36 | LUNG | Pulmonx CORP | 0% | — | 不变 |
| 37 | TRVI | Trevi Therapeutics Inc | 0% | NEW | 新建仓 |
| 38 | ✓ | 0% | — | 不变 | |
| 39 | HROW | Harrow Inc | 0% | +5.49% | 加仓 |
| 40 | SKYE | Skye Bioscience Inc | 0% | — | 不变 |
| 41 | PTGX | Protagonist Therapeutics Inc | 0% | EXIT | 清仓 |
| 42 | VRDN | Viridian Therapeutics Inc | 0% | EXIT | 清仓 |
| 43 | RGEN 1 12-15-28债券 | Repligen CORP | 0% | -12.50% | 减仓 |
| 44 | REPL | Replimune Group Inc | 0% | -1.03% | 减仓 |
| 45 | CELC | Celcuity Inc | 0% | — | 不变 |
| 46 | BCAX | Bicara Therapeutics Inc | 0% | +8.10% | 加仓 |
| 47 | APGE | Apogee Therapeutics Inc | -0.1% | — | 不变 |
| 48 | ✓ | Zura Bio LTD | -0.1% | — | 不变 |
| 49 | CUTR 2.25 06-01-28债券 | Cutera Inc | -0.1% | EXIT | 清仓 |
| 50 | CUTR 4 06-01-29债券 | Cutera Inc | -0.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Braidwell LP 在 Q1 2025 季度的美股持仓总市值约为 US$27.0亿，共申报了 64 个公开持股仓位。
在 Q1 2025 季度，Braidwell LP 按市值排列的前三大核心持股分别为：GH 1.25 02-15-31 (8.0%)、NVCR 0 11-01-25 (4.8%)、NBIX (4.6%)。其中最大持股仓位 GH 1.25 02-15-31 占据整体投资组合约 8.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
GH 1.25 02-15-31
市值: US$2.3亿
本季最大获利了结 / 清仓标的
GH 0 11-15-27
前期市值: US$2.3亿
在 Q1 2025 季度中，Braidwell LP 共进行了 72 项持仓异动，包含新建仓 13 个仓位、加仓 17 个仓位、减仓 20 个仓位以及清仓 22 个仓位。 其中最大新建仓标的为 GH 1.25 02-15-31。 本季清仓仓位包含 GH 0 11-15-27。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。